- Home
- WOOF vs EYPT Comparison
WOOF vs EYPT Comparison
Compare WOOF & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WOOF
- EYPT
- Stock Information
- Founded
- WOOF 1965
- EYPT 1987
- Country
- WOOF United States
- EYPT United States
- Employees
- WOOF N/A
- EYPT N/A
- Industry
- WOOF Other Specialty Stores
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- WOOF Consumer Discretionary
- EYPT Industrials
- Exchange
- WOOF Nasdaq
- EYPT Nasdaq
- Market Cap
- WOOF 986.5M
- EYPT 967.4M
- IPO Year
- WOOF 2021
- EYPT 2005
- Fundamental
- Price
- WOOF $3.16
- EYPT $12.43
- Analyst Decision
- WOOF Hold
- EYPT Strong Buy
- Analyst Count
- WOOF 11
- EYPT 5
- Target Price
- WOOF $3.91
- EYPT $27.40
- AVG Volume (30 Days)
- WOOF 2.1M
- EYPT 1.4M
- Earning Date
- WOOF 12-04-2025
- EYPT 11-05-2025
- Dividend Yield
- WOOF N/A
- EYPT N/A
- EPS Growth
- WOOF N/A
- EYPT N/A
- EPS
- WOOF N/A
- EYPT N/A
- Revenue
- WOOF $6,045,495,000.00
- EYPT $51,898,000.00
- Revenue This Year
- WOOF N/A
- EYPT N/A
- Revenue Next Year
- WOOF $0.98
- EYPT N/A
- P/E Ratio
- WOOF N/A
- EYPT N/A
- Revenue Growth
- WOOF N/A
- EYPT 2.99
- 52 Week Low
- WOOF $2.28
- EYPT $3.91
- 52 Week High
- WOOF $6.29
- EYPT $14.91
- Technical
- Relative Strength Index (RSI)
- WOOF 35.06
- EYPT 49.96
- Support Level
- WOOF $3.10
- EYPT $11.55
- Resistance Level
- WOOF $3.87
- EYPT $12.47
- Average True Range (ATR)
- WOOF 0.16
- EYPT 0.79
- MACD
- WOOF -0.06
- EYPT 0.05
- Stochastic Oscillator
- WOOF 9.74
- EYPT 54.70
About WOOF Petco Health and Wellness Company Inc.
Petco Health and Wellness Co Inc is a pet specialty retailer focused on improving the lives of pets, pet parents, and its own partners with pet care centers in approximately 50 states, the District of Columbia and Puerto Rico. The Company also offers an expanded range of consumables, supplies, and services through its website and mobile app.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.